Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2025 Earnings Call Transcript May 6, 2025
Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.01.
Operator: Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q1 2025 Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded. After the speaker’s presentation, there will be a question-and-answer session....
